Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buprenorphine TDS vs Oxycodone/Acetaminophen in Chronic Low Back Pain
NCT00315874Phase 3Completed
- Sponsor
- Purdue Pharma
- Start
- Apr 1997
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of buprenorphine in chronic low back pain (CLBP) (5 arms), sponsored by Purdue Pharma. Primary endpoint: Pain on average and pain right now scores at Day 60. Started Apr 1997; status: completed.
02
Drugs
buprenorphine
03
Conditions
chronic low back pain (CLBP)
Beyond the preview
Go deeper on NCT00315874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00315874.